Conchita Vens
Papers
1
Total Citations
32
H-Index
1
About
Conchita Vens is a leading radiobiologist whose research focuses on the cellular response to DNA damage, particularly in the context of cancer radiotherapy. Her major contributions lie in understanding how tumors repair radiation-induced DNA double-strand breaks and identifying vulnerabilities that can be exploited for therapeutic gain. Vens is best known for her work on ATM kinase inhibitors, where she co-authored a landmark 2017 study identifying a novel ATM inhibitor that selectively radiosensitizes cancer cells while sparing normal tissues. This paper, which has garnered 32 citations, represents a significant step toward improving the therapeutic ratio in radiation oncology. Her research integrates molecular biology, pharmacology, and translational oncology to develop strategies that enhance tumor cell killing while reducing collateral damage to healthy tissues. Vens's work has implications for head and neck cancers and other solid tumors, where radioresistance remains a clinical challenge. Through her collaborative efforts at the Netherlands Cancer Institute, she has helped bridge the gap between basic DNA repair mechanisms and clinical radiotherapy applications, making her a respected figure in the field of radiation biology and cancer therapeutics.
Research Focus
Key Achievements
Top Papers
- 1